1. Home
  2. ATRC vs BLND Comparison

ATRC vs BLND Comparison

Compare ATRC & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • BLND
  • Stock Information
  • Founded
  • ATRC 2000
  • BLND 2012
  • Country
  • ATRC United States
  • BLND United States
  • Employees
  • ATRC N/A
  • BLND N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • BLND EDP Services
  • Sector
  • ATRC Health Care
  • BLND Technology
  • Exchange
  • ATRC Nasdaq
  • BLND Nasdaq
  • Market Cap
  • ATRC 1.6B
  • BLND 925.5M
  • IPO Year
  • ATRC 2005
  • BLND 2021
  • Fundamental
  • Price
  • ATRC $31.76
  • BLND $3.53
  • Analyst Decision
  • ATRC Strong Buy
  • BLND Buy
  • Analyst Count
  • ATRC 10
  • BLND 7
  • Target Price
  • ATRC $49.60
  • BLND $4.93
  • AVG Volume (30 Days)
  • ATRC 424.4K
  • BLND 2.0M
  • Earning Date
  • ATRC 07-29-2025
  • BLND 08-07-2025
  • Dividend Yield
  • ATRC N/A
  • BLND N/A
  • EPS Growth
  • ATRC N/A
  • BLND N/A
  • EPS
  • ATRC N/A
  • BLND N/A
  • Revenue
  • ATRC $480,076,000.00
  • BLND $164,949,000.00
  • Revenue This Year
  • ATRC $14.63
  • BLND N/A
  • Revenue Next Year
  • ATRC $12.62
  • BLND $28.57
  • P/E Ratio
  • ATRC N/A
  • BLND N/A
  • Revenue Growth
  • ATRC 15.79
  • BLND 15.07
  • 52 Week Low
  • ATRC $20.20
  • BLND $2.27
  • 52 Week High
  • ATRC $43.11
  • BLND $5.53
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 44.34
  • BLND 57.30
  • Support Level
  • ATRC $30.85
  • BLND $3.25
  • Resistance Level
  • ATRC $33.15
  • BLND $3.42
  • Average True Range (ATR)
  • ATRC 0.98
  • BLND 0.14
  • MACD
  • ATRC -0.10
  • BLND 0.02
  • Stochastic Oscillator
  • ATRC 36.52
  • BLND 97.78

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

Share on Social Networks: